Acquiring Company
Pfizer
Acquired Company
Metsera
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsBiotechnologyHealth CareDescription
Pfizer has received early clearance from the U.S. Federal Trade Commission for its pending acquisition of Metsera. This clearance satisfies the regulatory requirements under the Hart-Scott-Rodino Antitrust Improvements Act. The acquisition was previously announced and is set to finalize soon.
Quick answer
Pfizer is acquiring Metsera, announced October 31, 2025. Pfizer is based in New York, New York, United States.
- How much did Pfizer pay for Metsera?
- The deal value was not disclosed.
- Where are Pfizer and Metsera based?
- Pfizer is based in New York, New York, United States.
- Who are the decision-makers at Pfizer?
- Fundz holds 2 contacts at Pfizer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Day One to acquire Mersana for $130 million, $130M (November 30, 2025)
- Pfizer to acquire Metsera for $10 billion, $10B (November 15, 2025)
- Pfizer increases bid for Metsera in bidding war (November 8, 2025)
- Pfizer acquires Metsera for $7.3 billion, $7.3B (October 13, 2025)
- Pfizer to acquire Metsera for $7.3 billion, $7.3B (September 22, 2025)
- XOMA Royalty acquires LAVA Therapeutics N.V. (November 21, 2025)
Who to call at Pfizer, and when
When Pfizer changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Metsera?
Metsera was acquired by Pfizer, based in New York. The deal was reported on October 31, 2025. Pfizer is publicly traded (PFE) and operates in Biotechnology.
When did Pfizer acquire Metsera?
Pfizer's acquisition of Metsera was reported on October 31, 2025. Pfizer has received early clearance from the U.S. Federal Trade Commission for its pending acquisition of Metsera. This clearance satisfies the regulatory requirements under the Hart-Scott-Rodino Antitrust Improvements Act. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Metsera do?
Metsera is a weight-loss drug developer founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.